| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Shlomo Rotshenker | |
| P2860 | cites work | Glial inhibition of CNS axon regeneration | Q24648851 |
| Galectins: structure, function and therapeutic potential | Q28283659 | ||
| Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation | Q28290361 | ||
| Phosphatidylinositol 3-kinase, phosphoinositide-specific phospholipase-Cgamma and protein kinase-C signal myelin phagocytosis mediated by complement receptor-3 alone and combined with scavenger receptor-AI/II in macrophages | Q28507535 | ||
| Microglia: active sensor and versatile effector cells in the normal and pathologic brain | Q29547240 | ||
| Microglia-mediated neurotoxicity: uncovering the molecular mechanisms | Q29547835 | ||
| Microglia: a sensor for pathological events in the CNS | Q29620556 | ||
| Phagocytic properties of microglia in vitro: implications for a role in multiple sclerosis and EAE. | Q34309554 | ||
| Peripheral nerve injury induces Schwann cells to express two macrophage phenotypes: phagocytosis and the galactose-specific lectin MAC-2. | Q34341111 | ||
| Galectin-3: an open-ended story | Q34494555 | ||
| Degeneration and regeneration of the peripheral nervous system: from Augustus Waller's observations to neuroinflammation | Q34591798 | ||
| Macrophage responses and myelin clearance during Wallerian degeneration: relevance to immune-mediated demyelination | Q35513528 | ||
| Microglia and Macrophage Activation and the Regulation of Complement-Receptor-3 (CR3/MAC-1)-Mediated Myelin Phagocytosis in Injury and Disease | Q35538811 | ||
| Therapeutic approaches to promoting axonal regeneration in the adult mammalian spinal cord. | Q36687839 | ||
| Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression. | Q36692860 | ||
| The brain as a target for inflammatory processes and neuroprotective strategies | Q37031200 | ||
| The cytokine network of wallerian degeneration: IL-10 and GM-CSF. | Q40840379 | ||
| Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain | Q40917096 | ||
| Granulocyte macrophage colony stimulating factor produced in lesioned peripheral nerves induces the up-regulation of cell surface expression of MAC-2 by macrophages and Schwann cells | Q41922181 | ||
| The macrophage response to central and peripheral nerve injury. A possible role for macrophages in regeneration | Q42938731 | ||
| Non-PKC DAG/phorbol-ester receptor(s) inhibit complement receptor-3 and nPKC inhibit scavenger receptor-AI/II-mediated myelin phagocytosis but cPKC, PI3k, and PLCgamma activate myelin phagocytosis by both | Q46865752 | ||
| Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions | Q46891042 | ||
| Complement-receptor-3 and scavenger-receptor-AI/II mediated myelin phagocytosis in microglia and macrophages | Q48378086 | ||
| Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. | Q50656963 | ||
| Distinct inflammatory stimuli induce different patterns of myelin phagocytosis and degradation in recruited macrophages. | Q52542047 | ||
| The Membrane Attack Complex of Complement Causes Severe Demyelination Associated with Acute Axonal Injury | Q61709665 | ||
| Resident microglia and hematogenous macrophages as phagocytes in adoptively transferred experimental autoimmune transferred experimental autoimmune encephalomyelitis: An investigation using rat radiation bone marrow chimeras | Q61709781 | ||
| Isolation of membrane attack complex of complement from myelin membranes treated with serum complement | Q71277202 | ||
| Deficient activation of microglia during optic nerve degeneration | Q71739718 | ||
| Upregulation of the macrophage scavenger receptor in response to different forms of injury in the CNS | Q72469240 | ||
| Mac-2, a novel 32,000 Mr mouse macrophage subpopulation-specific antigen defined by monoclonal antibodies | Q72656941 | ||
| Galectin-3/MAC-2 in experimental allergic encephalomyelitis | Q73320823 | ||
| Modulation (inhibition and augmentation) of complement receptor-3-mediated myelin phagocytosis | Q74151811 | ||
| Easing the brakes on spinal cord repair | Q80810720 | ||
| Galectin-3/MAC-2, Ras and PI3K activate complement receptor-3 and scavenger receptor-AI/II mediated myelin phagocytosis in microglia | Q81613971 | ||
| Spatiotemporal organization of Ras signaling: rasosomes and the galectin switch | Q83324479 | ||
| P433 | issue | 1-2 | |
| P921 | main subject | phagocytosis | Q184726 |
| microglia | Q1622829 | ||
| immune function | Q124683452 | ||
| P304 | page(s) | 99-103 | |
| P577 | publication date | 2009-02-28 | |
| P1433 | published in | Journal of Molecular Neuroscience | Q15708870 |
| P1476 | title | The role of Galectin-3/MAC-2 in the activation of the innate-immune function of phagocytosis in microglia in injury and disease | |
| P478 | volume | 39 |
| Q38010639 | Achieving CNS axon regeneration by manipulating convergent neuro-immune signaling |
| Q42223040 | Activated Microglia Desialylate and Phagocytose Cells via Neuraminidase, Galectin-3, and Mer Tyrosine Kinase |
| Q37971896 | Animal Models of MS Reveal Multiple Roles of Microglia in Disease Pathogenesis |
| Q41314097 | Anti-Inflammatory Targets for the Treatment of Reperfusion Injury in Stroke |
| Q53325333 | Aβ potentiates inflammatory activation of glial cells induced by scavenger receptor ligands and inflammatory mediators in culture. |
| Q39015586 | CX3CR1 RNAi inhibits hypoxia-induced microglia activation via p38MAPK/PKC pathway |
| Q27312602 | Cell-autonomous progeroid changes in conditional mouse models for repair endonuclease XPG deficiency |
| Q33956951 | Chronic cortical and subcortical pathology with associated neurological deficits ensuing experimental herpes encephalitis |
| Q33939361 | Chronic upregulation of activated microglia immunoreactive for galectin-3/Mac-2 and nerve growth factor following diffuse axonal injury |
| Q36162628 | Complement receptor-3 negatively regulates the phagocytosis of degenerated myelin through tyrosine kinase Syk and cofilin |
| Q40570716 | Development and characterization of a human microglia cell model of HIV-1 infection |
| Q34008297 | Differential cellular localization of galectin-1 and galectin-3 in the regressing corpus luteum of mice and their possible contribution to luteal cell elimination |
| Q35058419 | Early gene expression changes in spinal cord from SOD1(G93A) Amyotrophic Lateral Sclerosis animal model |
| Q33781107 | Effects of combinatorial treatment with pituitary adenylate cyclase activating peptide and human mesenchymal stem cells on spinal cord tissue repair |
| Q50531818 | Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer's Disease Models. |
| Q34585839 | Evidence for neuroinflammatory and microglial changes in the cerebral response to sleep loss |
| Q37823854 | Expanding the universe of cytokines and pattern recognition receptors: galectins and glycans in innate immunity |
| Q44548551 | Expression and detrimental role of hematopoietic prostaglandin D synthase in spinal cord contusion injury |
| Q64092815 | Galectin-3 (MAC-2) Controls Microglia Phenotype Whether Amoeboid and Phagocytic or Branched and Non-phagocytic by Regulating the Cytoskeleton |
| Q42706786 | Galectin-3 alters the lateral mobility and clustering of β1-integrin receptors |
| Q90073141 | Galectin-3 as a Next-Generation Biomarker for Detecting Early Stage of Various Diseases |
| Q48427366 | Galectin-3 is required for resident microglia activation and proliferation in response to ischemic injury. |
| Q57157917 | Galectin-3-Mediated Glial Crosstalk Drives Oligodendrocyte Differentiation and (Re)myelination |
| Q39194291 | Genetic deletion of galectin-3 enhances neuroinflammation, affects microglial activation and contributes to sub-chronic injury in experimental neonatal focal stroke |
| Q43187402 | Glaucomatous optic nerve injury involves early astrocyte reactivity and late oligodendrocyte loss. |
| Q61443230 | High cholesterol triggers white matter alterations and cognitive deficits in a mouse model of cerebrovascular disease: benefits of simvastatin |
| Q33857828 | Increased White Matter Inflammation in Aging- and Alzheimer's Disease Brain |
| Q34747895 | Increased transforming growth factor-β1 modulates glutamate receptor expression in the hippocampus |
| Q38079579 | Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis. |
| Q35916590 | Maternal immune activation evoked by polyinosinic:polycytidylic acid does not evoke microglial cell activation in the embryo |
| Q50242326 | Microglia proliferation is controlled by P2X7 receptors in a Pannexin-1-independent manner during early embryonic spinal cord invasion. |
| Q39428068 | Myelin as an inflammatory mediator: Myelin interactions with complement, macrophages, and microglia in spinal cord injury. |
| Q30497967 | Myelination transition zone astrocytes are constitutively phagocytic and have synuclein dependent reactivity in glaucoma. |
| Q27306025 | N17 Modifies mutant Huntingtin nuclear pathogenesis and severity of disease in HD BAC transgenic mice |
| Q42395481 | Neuroinflammation in advanced canine glaucoma. |
| Q27001219 | Neurotrauma and inflammation: CNS and PNS responses |
| Q60923221 | Peripheral nerve regeneration and intraneural revascularization |
| Q57454605 | Peripherally derived macrophages modulate microglial function to reduce inflammation after CNS injury |
| Q47739408 | Peroxisome proliferator-activated receptor γ (PPARγ): A master gatekeeper in CNS injury and repair |
| Q33574527 | Phagocytosis of microglia in the central nervous system diseases |
| Q51129031 | Progressive Motor Deficit is Mediated by the Denervation of Neuromuscular Junctions and Axonal Degeneration in Transgenic Mice Expressing Mutant (P301S) Tau Protein. |
| Q34581276 | Reduction in antioxidant enzyme expression and sustained inflammation enhance tissue damage in the subacute phase of spinal cord contusive injury |
| Q34488431 | Schwann cell-derived Apolipoprotein D controls the dynamics of post-injury myelin recognition and degradation |
| Q34510368 | Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential |
| Q30583027 | Transcellular degradation of axonal mitochondria. |
| Q26999323 | Wallerian degeneration: the innate-immune response to traumatic nerve injury |
| Q30656553 | Who let the dogs out?: detrimental role of Galectin-3 in hypoperfusion-induced retinal degeneration |
Search more.